Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders' Equity (Unaudited)

v3.24.2.u1
Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Class A Preferred Shares
Preferred Stock
Class A Common Shares
Common Shares
Common Shares
Common Shares
Common Stock Issuable
Additional Paid-in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2022     $ 11 $ 1,109 $ 374,522 $ (329,369) $ 46,273
Balances (in shares) at Dec. 31, 2022 250,000 845,385 7,100,111        
Issuance of common shares - Founders Agreement       (1,109) 1,109    
Issuance of common shares - Founders Agreement (in shares)     187,134        
Issuance of common shares under ESPP         88   88
Issuance of common shares under ESPP (in shares)     12,642        
Stock-based compensation expenses         280   280
Stock-based compensation expenses (in shares)     22,097        
Exercise of warrants (in shares)     93        
Reverse Split (15:1) adjustment     $ (10)   10    
Fractional share adjustment (in shares)     (1,633)        
Net Income (Loss)           (32,928) (32,928)
Balances at Jun. 30, 2023     $ 1   376,009 (362,297) 13,713
Balances (in shares) at Jun. 30, 2023 250,000 845,385 7,320,444        
Balances at Mar. 31, 2023     $ 1   375,876 (346,062) 29,815
Balances (in shares) at Mar. 31, 2023 250,000 845,385 7,293,242        
Issuance of common shares under ESPP         88   88
Issuance of common shares under ESPP (in shares)     12,642        
Stock-based compensation expenses         45   45
Stock-based compensation expenses (in shares)     16,193        
Fractional share adjustment (in shares)     (1,633)        
Net Income (Loss)           (16,235) (16,235)
Balances at Jun. 30, 2023     $ 1   376,009 (362,297) 13,713
Balances (in shares) at Jun. 30, 2023 250,000 845,385 7,320,444        
Balances at Dec. 31, 2023     $ 1 591 380,502 (380,971) 123
Balances (in shares) at Dec. 31, 2023 250,000 845,385 8,374,869        
Issuance of common shares - Founders Agreement       (477) 640   163
Issuance of common shares - Founders Agreement (in shares)     928,277        
Issuance of common shares, net of offering costs - Public Offerings       $ (114) 5,379   5,265
Issuance of common shares, net of offering costs - Public Offerings (in shares)     4,251,003        
Issuance of common shares under ESPP         48   $ 48
Issuance of common shares under ESPP (in shares)     47,463       128,352
Stock-based compensation expenses         (542)   $ (542)
Stock-based compensation expenses (in shares)     5,573        
Exercise of warrants     $ 2   1   3
Exercise of warrants (in shares)     20,490,874        
Net Income (Loss)           (13,390) (13,390)
Balances at Jun. 30, 2024     $ 3   386,028 (394,361) (8,330)
Balances (in shares) at Jun. 30, 2024 250,000 845,385 34,098,059        
Balances at Mar. 31, 2024     $ 1   381,218 (386,162) (4,943)
Balances (in shares) at Mar. 31, 2024 250,000 845,385 9,545,541        
Issuance of common shares - Founders Agreement         163   163
Issuance of common shares - Founders Agreement (in shares)     575,191        
Issuance of common shares, net of offering costs - Public Offerings         5,265   5,265
Issuance of common shares, net of offering costs - Public Offerings (in shares)     4,185,000        
Issuance of common shares under ESPP (in shares)     5,689        
Stock-based compensation expenses         (619)   (619)
Exercise of warrants     $ 2   1   3
Exercise of warrants (in shares)     19,786,638        
Net Income (Loss)           (8,199) (8,199)
Balances at Jun. 30, 2024     $ 3   $ 386,028 $ (394,361) $ (8,330)
Balances (in shares) at Jun. 30, 2024 250,000 845,385 34,098,059